• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑癌基因 p53 功能获得性突变与肿瘤侵袭转移

Gain-of-Function Mutations in p53 in Cancer Invasiveness and Metastasis.

机构信息

Department of Large Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, 100 Nowoursynowska St., 02-797 Warsaw, Poland.

出版信息

Int J Mol Sci. 2020 Feb 17;21(4):1334. doi: 10.3390/ijms21041334.

DOI:10.3390/ijms21041334
PMID:32079237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7072881/
Abstract

Forty years of research has proven beyond any doubt that p53 is a key regulator of many aspects of cellular physiology. It is best known for its tumor suppressor function, but it is also a regulator of processes important for maintenance of homeostasis and stress response. Its activity is generally antiproliferative and when the cell is damaged beyond repair or intensely stressed the p53 protein contributes to apoptosis. Given its key role in preventing cancer it is no wonder that it is the most frequently mutated gene in human cancer. Surprisingly, a subset of missense mutations occurring in p53 (gain-of-function) cause it to lose its suppressor activity and acquire new functionalities that turn the tumor suppressor protein into an oncoprotein. A solid body of evidence exists demonstrating increased malignancy of cancers with mutated p53 in all aspects considered "hallmarks of cancer". In this review, we summarize current findings concerning the cellular processes altered by gain-of-function mutations in p53 and their influence on cancer invasiveness and metastasis. We also present the variety of molecular mechanisms regulating these processes, including microRNA, direct transcriptional regulation, protein-protein interactions, and more.

摘要

四十年的研究无可置疑地证明,p53 是细胞生理多方面的关键调节因子。它最广为人知的功能是作为肿瘤抑制因子,但它也是维持内稳态和应激反应的重要过程的调节剂。它的活性通常具有抗增殖作用,当细胞受损无法修复或受到强烈压力时,p53 蛋白会促进细胞凋亡。鉴于其在预防癌症方面的关键作用,p53 是人类癌症中最常发生突变的基因也就不足为奇了。令人惊讶的是,p53 中发生的一小部分错义突变(获得功能)导致其失去抑制活性,并获得新的功能,将肿瘤抑制蛋白转化为癌蛋白。大量证据表明,在所有被认为是“癌症特征”的方面,带有突变 p53 的癌症的恶性程度都有所增加。在这篇综述中,我们总结了目前关于 p53 获得功能突变改变的细胞过程及其对癌症侵袭和转移的影响的研究结果。我们还介绍了调节这些过程的多种分子机制,包括 microRNA、直接转录调控、蛋白-蛋白相互作用等。

相似文献

1
Gain-of-Function Mutations in p53 in Cancer Invasiveness and Metastasis.抑癌基因 p53 功能获得性突变与肿瘤侵袭转移
Int J Mol Sci. 2020 Feb 17;21(4):1334. doi: 10.3390/ijms21041334.
2
Mutant p53 exerts oncogenic effects through microRNAs and their target gene networks.突变型 p53 通过 microRNAs 及其靶基因网络发挥致癌作用。
FEBS Lett. 2014 Aug 19;588(16):2610-5. doi: 10.1016/j.febslet.2014.03.054. Epub 2014 Apr 12.
3
The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer.miR-644a/CTBP1/p53轴通过同时抑制乳腺癌细胞的存活和上皮-间质转化来抑制耐药性。
Oncotarget. 2016 Aug 2;7(31):49859-49877. doi: 10.18632/oncotarget.10489.
4
Mutant p53 on the Path to Metastasis.突变型p53在转移进程中的作用
Trends Cancer. 2020 Jan;6(1):62-73. doi: 10.1016/j.trecan.2019.11.004. Epub 2019 Dec 16.
5
Mutant p53 drives invasion in breast tumors through up-regulation of miR-155.突变型 p53 通过上调 miR-155 驱动乳腺癌肿瘤的侵袭。
Oncogene. 2013 Jun 13;32(24):2992-3000. doi: 10.1038/onc.2012.305. Epub 2012 Jul 16.
6
Mutant p53 induces EZH2 expression and promotes epithelial-mesenchymal transition by disrupting p68-Drosha complex assembly and attenuating miR-26a processing.突变型p53通过破坏p68-Drosha复合体组装并减弱miR-26a加工过程来诱导EZH2表达并促进上皮-间质转化。
Oncotarget. 2015 Dec 29;6(42):44660-74. doi: 10.18632/oncotarget.6350.
7
Genome-Wide Small RNA Sequencing Identifies MicroRNAs Deregulated in Non-Small Cell Lung Carcinoma Harboring Gain-of-Function Mutant p53.全基因组小 RNA 测序鉴定出功能获得性突变 p53 非小细胞肺癌中失调的 microRNAs。
Genes (Basel). 2019 Oct 28;10(11):852. doi: 10.3390/genes10110852.
8
Diverse and cancer type‑specific roles of the p53 R248Q gain‑of‑function mutation in cancer migration and invasiveness.p53 R248Q 功能获得性突变在癌症迁移和侵袭中的多样化和肿瘤类型特异性作用。
Int J Oncol. 2019 Apr;54(4):1168-1182. doi: 10.3892/ijo.2019.4723. Epub 2019 Feb 22.
9
Friend or Foe: MicroRNAs in the p53 network.敌友难辨:p53 网络中的 microRNAs
Cancer Lett. 2018 Apr 10;419:96-102. doi: 10.1016/j.canlet.2018.01.013. Epub 2018 Jan 9.
10
[Advances on mutant p53 research].[突变型p53研究进展]
Yi Chuan. 2008 Jun;30(6):697-703. doi: 10.3724/sp.j.1005.2008.00697.

引用本文的文献

1
The Multifaceted Role of p53 in Cancer Molecular Biology: Insights for Precision Diagnosis and Therapeutic Breakthroughs.p53在癌症分子生物学中的多面角色:精准诊断与治疗突破的见解
Biomolecules. 2025 Jul 27;15(8):1088. doi: 10.3390/biom15081088.
2
The effects of two combined methods of P53 expression and preoperative serum CEA detection on the prognosis of colorectal cancer.P53表达与术前血清癌胚抗原检测两种联合方法对结直肠癌预后的影响
Front Oncol. 2025 Jul 21;15:1590836. doi: 10.3389/fonc.2025.1590836. eCollection 2025.
3
The Role of p53 Mutations in Early and Late Response to Mitotic Aberrations.p53突变在对有丝分裂异常的早期和晚期反应中的作用。
Biomolecules. 2025 Feb 8;15(2):244. doi: 10.3390/biom15020244.
4
Genetically Engineered Brain Organoids Recapitulate Spatial and Developmental States of Glioblastoma Progression.基因工程化脑类器官概括了胶质母细胞瘤进展的空间和发育状态。
Adv Sci (Weinh). 2025 Mar;12(10):e2410110. doi: 10.1002/advs.202410110. Epub 2025 Jan 21.
5
Exosomal AHSG in ovarian cancer ascites inhibits malignant progression of ovarian cancer by p53/FAK/Src signaling.卵巢癌腹水中的外泌体AHSG通过p53/FAK/Src信号通路抑制卵巢癌的恶性进展。
Transl Cancer Res. 2024 Oct 31;13(10):5365-5380. doi: 10.21037/tcr-24-789. Epub 2024 Oct 29.
6
Emerging Tumor-Agnostic Molecular Targets.新兴的肿瘤不可知论的分子靶点。
Mol Cancer Ther. 2024 Nov 4;23(11):1544-1554. doi: 10.1158/1535-7163.MCT-23-0725.
7
2-(4-Benzyloxy-3-methoxyphenyl)-5-(carbethoxyethylene)-7-methoxy-benzofuran, a Benzofuran Derivative, Suppresses Metastasis Effects in P53-Mutant Hepatocellular Carcinoma Cells.2-(4-苄氧基-3-甲氧基苯基)-5-(乙氧羰基乙烯基)-7-甲氧基苯并呋喃,一种苯并呋喃衍生物,可抑制p53突变型肝癌细胞的转移效应。
Biomedicines. 2023 Jul 19;11(7):2027. doi: 10.3390/biomedicines11072027.
8
p53 Modulates Radiosensitivity in Head and Neck Cancers-From Classic to Future Horizons.p53调节头颈癌的放射敏感性——从经典到未来展望
Diagnostics (Basel). 2022 Dec 5;12(12):3052. doi: 10.3390/diagnostics12123052.
9
Immunoexpression of p53 mutant-type in Iranian patients with primary and recurrence oral squamous cell carcinoma.伊朗原发性和复发性口腔鳞状细胞癌患者中p53突变型的免疫表达
Eur J Transl Myol. 2022 Nov 22;33(1):10847. doi: 10.4081/ejtm.2022.10847.
10
Cytochrome P450 27C1 Level Dictates Lung Cancer Tumorigenicity and Sensitivity towards Multiple Anticancer Agents and Its Potential Interplay with the IGF-1R/Akt/p53 Signaling Pathway.细胞色素 P450 27C1 水平决定肺癌的肿瘤发生能力和对多种抗癌药物的敏感性及其与 IGF-1R/Akt/p53 信号通路的潜在相互作用。
Int J Mol Sci. 2022 Jul 16;23(14):7853. doi: 10.3390/ijms23147853.

本文引用的文献

1
Genome-Wide Small RNA Sequencing Identifies MicroRNAs Deregulated in Non-Small Cell Lung Carcinoma Harboring Gain-of-Function Mutant p53.全基因组小 RNA 测序鉴定出功能获得性突变 p53 非小细胞肺癌中失调的 microRNAs。
Genes (Basel). 2019 Oct 28;10(11):852. doi: 10.3390/genes10110852.
2
P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs.P53-R273H 突变通过调节特定的长链非编码 RNA 增强结直肠癌干细胞特性。
J Exp Clin Cancer Res. 2019 Aug 28;38(1):379. doi: 10.1186/s13046-019-1375-9.
3
Mutant p53 increases exosome-mediated transfer of miR-21-3p and miR-769-3p to promote pulmonary metastasis.突变型p53增加外泌体介导的miR-21-3p和miR-769-3p转移以促进肺转移。
Chin J Cancer Res. 2019 Jun;31(3):533-546. doi: 10.21147/j.issn.1000-9604.2019.03.15.
4
Diverse and cancer type‑specific roles of the p53 R248Q gain‑of‑function mutation in cancer migration and invasiveness.p53 R248Q 功能获得性突变在癌症迁移和侵袭中的多样化和肿瘤类型特异性作用。
Int J Oncol. 2019 Apr;54(4):1168-1182. doi: 10.3892/ijo.2019.4723. Epub 2019 Feb 22.
5
Mutant p53 regulates LPA signaling through lysophosphatidic acid phosphatase type 6.突变型 p53 通过溶血磷脂酸磷酸酶 6 调控 LPA 信号通路。
Sci Rep. 2019 Mar 26;9(1):5195. doi: 10.1038/s41598-019-41352-5.
6
P53, GHRH, inflammation and cancer.P53、GHRH、炎症与癌症。
EBioMedicine. 2018 Nov;37:557-562. doi: 10.1016/j.ebiom.2018.10.034. Epub 2018 Oct 19.
7
Inflammation and cancer.炎症与癌症。
Environ Health Prev Med. 2018 Oct 20;23(1):50. doi: 10.1186/s12199-018-0740-1.
8
ONZIN Upregulation by Mutant p53 Contributes to Osteosarcoma Metastasis Through the CXCL5-MAPK Signaling Pathway.突变型p53上调ONZIN通过CXCL5-MAPK信号通路促进骨肉瘤转移。
Cell Physiol Biochem. 2018;48(3):1099-1111. doi: 10.1159/000491976. Epub 2018 Jul 24.
9
Mutant p53 regulates enhancer-associated H3K4 monomethylation through interactions with the methyltransferase MLL4.突变型 p53 通过与甲基转移酶 MLL4 的相互作用调节增强子相关的 H3K4 单甲基化。
J Biol Chem. 2018 Aug 24;293(34):13234-13246. doi: 10.1074/jbc.RA118.003387. Epub 2018 Jun 28.
10
MiR-142-3p is downregulated in aggressive p53 mutant mouse models of pancreatic ductal adenocarcinoma by hypermethylation of its locus.miR-142-3p 的表达在具有侵袭性的 p53 突变型胰腺导管腺癌小鼠模型中受其基因座的高甲基化调控而下调。
Cell Death Dis. 2018 May 29;9(6):644. doi: 10.1038/s41419-018-0628-4.